Rades Dirk, Walz Jochen, Stalpers Lukas J A, Veninga Theo, Schulte Rainer, Obralic Nermina, Wildfang Ingeborg, Engenhart-Cabilic Rita, Hoskin Peter J, Schild Steven E
Department of Radiation Oncology, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
Eur Urol. 2006 May;49(5):846-52; discussion 852. doi: 10.1016/j.eururo.2005.11.004. Epub 2005 Dec 19.
For MSCC treatment, a short treatment time is desirable, especially if survival prognosis is poor. Survival depends on the primary tumor, extent of disease, performance status, ambulatory status, and the number of involved vertebrae. These factors may help to define the appropriate regimen for the individual patient. Our study compares short-course (1 x 8 Gy, 5 x 4 Gy) and long-course RT (10 x 3 Gy, 15 x 2.5 Gy, 20 x 2 Gy) for functional outcome in MSCC patients with renal cell carcinoma.
The following potential prognostic factors for functional outcome were retrospectively investigated: age, performance status, involved vertebra, ambulatory status, time of developing motor deficits before RT, radiation schedule (short-course RT, n=37; long-course RT, n=50).
Eighty-seven patients were included in this retrospective study, 25 patients (29%) showed improvement of motor function, 52 patients (60%) no change, 10 patients (11%) deterioration. 25% of non-ambulatory patients became ambulatory after RT. Functional outcome was affected by the time of developing motor deficits before RT (p<0.001). The RT schedule had no significant impact (p=0.91). In the short-course RT sub-group, functional outcome was similar for 1 x 8 Gy and 5 x 4 Gy (p=0.99).
Short-course and long-course RT appear similarly active for MSCC in patients with renal cell carcinoma. Short-course RT appears preferable, as it is means less patient discomfort. Because 1 x 8 Gy and 5 x 4 Gy were comparably effective, 1 x 8 Gy may be suggested the best actual choice.
对于转移性脊髓压迫症(MSCC)的治疗,理想的是治疗时间短,尤其是在生存预后较差的情况下。生存取决于原发肿瘤、疾病范围、身体状况、行走状态以及受累椎体的数量。这些因素有助于为个体患者确定合适的治疗方案。我们的研究比较了短疗程(1×8 Gy,5×4 Gy)和长疗程放疗(10×3 Gy,15×2.5 Gy,20×2 Gy)对肾细胞癌合并MSCC患者功能结局的影响。
回顾性研究以下可能影响功能结局的预后因素:年龄、身体状况、受累椎体、行走状态、放疗前出现运动功能障碍的时间、放疗方案(短疗程放疗,n = 37;长疗程放疗,n = 50)。
本回顾性研究纳入了87例患者,25例(29%)患者运动功能改善,52例(60%)无变化,10例(11%)恶化。25%的非行走患者放疗后能够行走。功能结局受放疗前出现运动功能障碍时间的影响(p<0.001)。放疗方案无显著影响(p = 0.91)。在短疗程放疗亚组中,1×8 Gy和5×4 Gy的功能结局相似(p = 0.99)。
短疗程和长疗程放疗对肾细胞癌合并MSCC患者的疗效似乎相似。短疗程放疗似乎更可取,因为它给患者带来的不适更少。由于1×8 Gy和5×4 Gy疗效相当,1×8 Gy可能是目前最佳的选择。